METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION- SENSITIVE PROSTATE CANCER

• 1. 酪氨酸激酶抑制剂和化学阉割联合治疗前列腺癌 [P] . 中国专利： CN1268061A . 2000-09-27
• 2. 一种提高阉割公鸡存活率的中药组合物、制备方法及应用 [P] . 中国专利： CN106075283B . 2021.05.11
• 3. METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION- SENSITIVE PROSTATE CANCER [P] . 世界知识产权组织专利： WO2020118252A1 . 2020-06-11

  机译： 治疗抗结直肠癌和抗结直肠癌的方法

• 4. USE OF THE ANTI-ALPHA-V INTEGRIN ANTIBODY DI17E6 IN THE PRODUCTION OF A MEDICAMENT AND TREATMENT OF PROSTATE CANCER, METHOD OF TREATING CASTRATION-RESISTANT PROSTATE CANCER (CRPC), METHOD OF DECLINING THE PSA LEVEL, METHOD OF REDUCING PAIN OCCURRING IN PROSTATE CANCER [P] . EA032117B1 . 2019-04-30

  机译： 抗α-V整合素抗体DI17E6在前列腺癌的药物生产和治疗中的应用，抗前列腺癌的治疗方法，降低PSA水平的方法，减少前列腺痛的方法

• 5. Methods of treating castration-resistant and castration-sensitive prostate cancer [P] . KR20210100145A . 2021-08-13

  机译： 处理抗阉割和阉料敏感前列腺癌的方法

• 1. Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy [J] . Yuan-Yuan Qu, Bo Dai, Yun-Yi Kong, 亚洲男性学杂志（英文版） . 2013,第001期
• 2. Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer: A Decade of Progress and Ongoing Discoveries [C] . Leonel Hernez-Aya, Maha Hussain Genitourinary Cancers Symposium. . 2014
• 3. Identification and Characterization of Novel Subtypes of Castration-Resistant Prostate Cancer [D] . Tang, Fanying. 2021
• 4. Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer [O] . Satoshi Tamada, Taro Iguchi, Minoru Kato, 2018
• 5. Phase I Study of Ixabepilone, Mitoxantrone, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy: A Study of the Department of Defense Prostate Cancer Clinical Trials Consortium [O] . Rosenberg, Jonathan E., Ryan, Charles J., Weinberg, Vivian K., 2009

• 1. Nonmetastatic castration-resistant prostate cancer: Novel agents to treat a lethal disease [J] . Ivan Henriquez ,Daniel Spratt ,Alfonso Gomez-Iturriaga . 世界临床肿瘤学杂志：英文版 . 2021,第1期
• 2. Bone markers predict survival in castration-resistant prostate cancer patients treated with docetaxel [J] . Takumi Endo1 ,Naoto Kamiya1 ,Hiroyoshi Suzuki1 . 世界临床泌尿杂志 . 2014,第002期
• 3. Metastatic hormone-sensitive prostate cancer:How should it be treated? [J] . Fernando López-Campos ,Carmen González-San Segundo ,Antonio JoséConde-Moreno . 世界临床肿瘤学杂志：英文版 . 2021,第2期
• 4. The neutrophil-to-lymphocyte ratio at the prostate-specific antigen nadir predicts the time to castration-resistant prostate cancer [J] . Genta Iwamoto ,Takashi Kawahara ,Yumiko Yokomizo . 亚洲泌尿外科杂志(英文) . 2021,第3期
• 5. 牙本质敏感的突破性治疗方法：含8％精氨酸和碳酸钙的高露洁专效抗敏牙膏如何有效地缓解牙齿敏感 [C] . . 2011年中国口腔护理用品工业学术研讨会 . 2011
• 6. 论性犯罪中的生物性治疗——以韩国“化学阉割”法案为视域展开 [A] . 何胜男 . 2014